UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of: July 2026
Commission file number: 001-36578
ENLIVEX LTD.
(Translation of registrant’s name into English)
14 Einstein Street, Nes Ziona, Israel 7403618
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
On July
29, 2026, Enlivex Ltd., a company organized under the laws of the State of Israel, issued
a press release providing an update on the Rain protocol trading metrics. A copy of the press release is furnished herewith as Exhibit
99.1 and is incorporated herein by reference.
| Exhibit No. |
|
|
| |
|
|
| 99.1 |
|
Press Release |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Enlivex
Ltd. |
| |
(Registrant) |
| |
|
| |
By: |
/s/
Oren Hershkovitz |
| |
Name: |
Oren
Hershkovitz |
| |
Title: |
Chief
Executive Officer |
Date: July 30, 2026
Exhibit
99.1

Enlivex
Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
| ● | As
of July 29, 2026, trading volume on the Rain protocol reached $860MM1 |
| | | |
| ● | 622%
month-over-month growth in trading volume during July 2026 vs June 2026 |
Nes-Ziona,
Israel, July 30, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality
longevity company powered by a prediction markets treasury, today provided an update on the Rain protocol trading metrics. Trading volume
on the Rain protocol reached $860 million, and experienced a substantial increase of 622% between the trading volume of June 2026 vs
July 2026.
According
to the Rain Foundation, the target trading volumes on the protocol are expected to increase substantially to $1.3 billion in 2027, $12
billion in 2028, and $33 billion in 2029. At these trading levels, gross fees received by the Rain Foundation are expected to be $49
million, $436 million and $1.2 billion, and the net fees allocated to buy-and-burn the RAIN token would be $24 million, $216 million
and $600 million, in 2027, 2028 and 2029, respectively.
Mr.
Shai Novik, Executive Chairman of Enlivex commented, “Prediction markets could reach $1 trillion in annual trading volume by 20302,
according to various analysts. We are pleased with the progress of the Rain protocol and believe that it has the potential to solidify
itself as the primary decentralized prediction market. We hope that as this trend continues, the Enlivex RAIN treasury portfolio will
be viewed and valued differently by investors.”
The
updated unaudited mark-to-market treasury metrics are publicly available on the Company’s website at https://enlivex.com/dashboard/.
Detailed information about the RAIN token’s listing on various exchanges, daily trading volume and other parameters can be found
on https://coinmarketcap.com/currencies/rain/.
About
Enlivex
Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced
clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis.
In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading
decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics
with exposure to the emerging prediction markets ecosystem.
| 1 | Data provided by the Rain Foundation |
| 2 | Source:
Industry analysis by Eilers and Krejcik Gaming (EKG), December 2025 |

Forward-looking
statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by
words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,”
“believes,” “should,” “would,” “could,” “intends,” “estimates,”
“suggests,” “target,” “has the potential to,” “goal,” and other words of similar meaning,
including statements relating to the anticipated benefits of the Company’s digital asset treasury strategy; the assets to be held
by the Company; the expected future market, price, trading activity, and liquidity of the RAIN token; the impact of expanded exchange
listings and increased token liquidity on market participation and accessibility; the potential effects of digital asset liquidity on
the liquidity of the Company’s ordinary shares; macroeconomic, political, and regulatory conditions surrounding digital assets;
the Company’s plans for value creation and strategic positioning; market size and growth opportunities; regulatory conditions;
competitive position; technological and market trends; future financial condition and performance; expected clinical trial results; market
opportunities for the results of current clinical studies and preclinical experiments; and the effectiveness of, and market opportunities
for, ALLOCETRA™ programs.
Each
forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk of failure
to realize the anticipated benefits of the Company’s digital asset treasury strategy; changes in business, market, financial, political,
and regulatory conditions; risks relating to the Company’s operations and business, including the highly volatile nature of the
price, trading volume, and liquidity of RAIN and other cryptocurrencies; risks associated with digital asset exchange listings, trading
venues, and market infrastructure; the risk that the price and liquidity of the Company’s ordinary shares may be correlated with
the price or liquidity of the digital assets it holds; risks related to increased competition in the industries in which the Company
operates; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally;
risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and those risks and uncertainties identified in the
Company’s filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only
as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except as required
by applicable law.
Enlivex
contact
Shachar Shlosberger
CFO
Enlivex Ltd.
shachar@enlivex.com